467
edits
Heart Failure: Difference between revisions
no edit summary
No edit summary |
No edit summary |
||
| Line 178: | Line 178: | ||
|Left ventricular wall motion | |Left ventricular wall motion | ||
|Akinesis, hypokinesis, dyskinesis | |Akinesis, hypokinesis, dyskinesis | ||
|Myocardial infarction/ischaemia, cardiomyopathy, myocarditis | |Myocardial infarction/ischaemia, | ||
cardiomyopathy, | |||
myocarditis | |||
|- | |- | ||
|Left ventricular end-diastolic diameter | |Left ventricular end-diastolic diameter | ||
| Line 195: | Line 199: | ||
|Left atrial volume index | |Left atrial volume index | ||
|Increased (volume >34 mL/m2) | |Increased (volume >34 mL/m2) | ||
|Increased filling pressures, mitral valve dysfunction | |Increased filling pressures, | ||
mitral valve dysfunction | |||
|- | |- | ||
|Left ventricular thickness | |Left ventricular thickness | ||
|Hypertrophy (>11 – 12 mm) | |Hypertrophy (>11 – 12 mm) | ||
|Hypertention, aortic stenosis, hypertrophic cardiomyopathy | |Hypertention, | ||
aortic stenosis, | |||
hypertrophic cardiomyopathy | |||
|- | |- | ||
|Valvular structure and function | |Valvular structure and function | ||
| Line 219: | Line 229: | ||
|Pericardium | |Pericardium | ||
|Effusion, haemopericardium, calcification | |Effusion, haemopericardium, calcification | ||
|Consider tamponade, malignancy, systemic disease, acute or chronic pericarditis, constrictive pericarditis | |Consider tamponade, | ||
malignancy, | |||
systemic disease, | |||
acute or chronic pericarditis, | |||
constrictive pericarditis | |||
|- | |- | ||
|Aortic outflow velocity time integral | |Aortic outflow velocity time integral | ||
| Line 231: | Line 249: | ||
|Inferior vena cava | |Inferior vena cava | ||
|Dilated, with no respiratory collapse | |Dilated, with no respiratory collapse | ||
|Increased right atrial pressures, right ventricular dysfunction, volume overload Pulmonary hypertention possible | |Increased right atrial pressures, | ||
right ventricular dysfunction, | |||
volume overload Pulmonary hypertention possible | |||
|} | |} | ||
| Line 774: | Line 796: | ||
|>7 weeks:::100-200mg s.i.d. | |>7 weeks:::100-200mg s.i.d. | ||
|- | |- | ||
| | |||
*'''Bisoprolol''' | *'''Bisoprolol''' | ||
|EF >30-45% and NYHA II-III | |EF >30-45% and NYHA II-III | ||